Max Voldman is an associate in Constantine Cannon’s Washington, DC office. Mr. Voldman’s practice is focused on representing whistleblowers under the federal False Claims Act and numerous state law equivalents, and the whistleblower programs of the Internal Revenue Service, Securities and Exchange Commission, Commodity Futures Trading Commission, and Department of Transportation.
Mr. Voldman has particular experience in combatting fraud in the healthcare industry. He is part of the legal team pursuing a qui tam case against UnitedHealth Group alleging the nation’s largest Medicare Advantage Organization submitted false claims for payment to the Medicare Program by improperly inflating its members’ risk scores. Mr. Voldman also has experience analyzing complex data sets, developing damages models, and assisting with statistical analyses. He has also published numerous articles on issues of healthcare law, whistleblower programs, and environmental issues.
Mr. Voldman received his J.D. from Georgetown University Law Center. During law school, Mr. Voldman served as a research assistant on taxation to Professor John Brooks and as the Symposium Editor for the Journal of Law and Public Policy.
Prior to law school, Mr. Voldman completed his undergraduate studies at the University of Illinois, where he was a member of the Mathematics Honors Society and graduated with a degree in Actuarial Science and a Minor in Business. Mr. Voldman also worked in State Farm’s actuarial science department and coached the debate team for a high school in Illinois, including one team that won the State Championship.
Mr. Voldman is fluent in Russian and admitted to practice in the State of Illinois, the District of Columbia, the United States District Court for the District of Columbia, and the United States District Court for the District of Colorado.
Whistleblower attorneys Mary Inman and Max Voldman published in RAC Monitor (March 27, 2019). Click here to read more.Read More
RAC Monitor publishes article by Partner Mary Inman and associate Max Voldman, Walgreens facing whistleblower lawsuit over Medicaid drug pricing. Click here to read the...Read More